Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | +1.53% |
|
+3.14% | -2.34% |
06-27 | Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target | MT |
06-24 | Sophia Genetics S. A. Launches New Residual Acute Myeloid Application | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 300M | |
+22.38% | 3,414B | |
+18.30% | 93.41B | |
+16.75% | 86.85B | |
+51.28% | 57.52B | |
-20.29% | 48.67B | |
+38.06% | 48.1B | |
-23.47% | 47.45B | |
+76.47% | 40.4B | |
-4.50% | 27.06B |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $12 From $13, Maintains Overweight Rating